Corrigendum to ‘Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study’: [The American Journal of Medicine (2022) Volume 136(12), 1461-1467]

Justin B. Echouffo-Tcheugui; Sui Zhang; John William McEvoy; Chiadi E. Ndumele; Ron C. Hoogeveen; Josef Coresh; Elizabeth Selvin

doi:10.1016/j.amjmed.2022.11.004

Corrigendum|Articles in Press

Corrigendum to ‘Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study’

[The American Journal of Medicine (2022) Volume 136(12), 1461-1467]

Justin B. Echouffo-Tcheugui, MD, PhD
Justin B. Echouffo-Tcheugui
Correspondence
Requests for reprints should be addressed to Justin B. Echouffo-Tcheugui, MD, PhD, Johns Hopkins University School of Medicine
Contact
Affiliations
Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, MD
Search for articles by this author
Sui Zhang, MPP
Sui Zhang
Affiliations
Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Search for articles by this author
John William McEvoy, MBBS, MHS
John William McEvoy
Affiliations
Division of Cardiology and National Institute for Prevention and Cardiovascular Health, National University of Ireland, Galway, Ireland
Search for articles by this author
Chiadi E. Ndumele, MD, PhD
Chiadi E. Ndumele
Affiliations
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
Search for articles by this author
Ron C. Hoogeveen, PhD
Ron C. Hoogeveen
Affiliations
Section of Cardiovascular Research, Baylor College of Medicine & Houston Methodist DeBakey Heart and Vascular Center, Houston, TX
Search for articles by this author
Josef Coresh, MD, PhD
Josef Coresh
Affiliations
Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Search for articles by this author
Elizabeth Selvin, PhD, MPH
Elizabeth Selvin
Affiliations
Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Search for articles by this author

Published:December 06, 2022DOI:https://doi.org/10.1016/j.amjmed.2022.11.004

The authors regret that the name of the first author was entered incorrectly on the title page and running head of the article, as well as in the issue's Table of Contents.

The name of the first author should be Justin B. Echouffo-Tcheugui, MD, PhD.

The authors would like to apologise for any inconvenience caused.

Article info

Publication history

Published online: December 06, 2022

Publication stage

In Press Journal Pre-Proof

Identification

DOI: https://doi.org/10.1016/j.amjmed.2022.11.004

Copyright

ScienceDirect

Access this article on ScienceDirect

Toggle Thumbstrip

Linked Article

Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study
The American Journal of MedicineVol. 135Issue 12
- Preview
  It remains unclear whether elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) can serve as a “risk equivalent” for cardiovascular disease to adults at high cardiovascular risk.
- Full-Text
- PDF

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes